Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2010
10/13/2010EP2239262A2 Fused ring heterocycle kinase modulators
10/13/2010EP2239253A1 Novel phenylpyrrole derivative
10/13/2010EP2238987A1 Sugar chain-related gene and use thereof
10/13/2010EP2238975A1 Gastric retention controlled drug delivery system
10/13/2010EP2238131A1 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
10/13/2010EP2238126A2 Derivatives of tetrahydroquinoxaline urea, preparation thereof and therapeutic application thereof
10/13/2010EP2238118A1 Method of synthesis of bosentan, its polymorphic forms and its salts
10/13/2010EP2238110A1 5.6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as antagonists for urotensine ii receptors
10/13/2010EP2237776A2 Compositions and methods for improving cardiovascular health
10/13/2010EP2134720B1 Heterocyclic spiro-compounds
10/13/2010EP2004658B1 Condensed imidazole derivatives as aromatase inhibitors
10/13/2010EP1902039B1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs
10/13/2010EP1765381B1 Treatment of neurological disorders with haematopoietic growth factors
10/13/2010EP1503785B1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
10/13/2010EP1381631B1 Human anti timp-1 antibodies
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010CN201602500U 一种保健枕 One kind Pillow
10/13/2010CN1939922B 5H-thiophene [3,4-C] pyrrole-4,6-diketone derivative for inhibiting cell release tumor necrosis factor
10/13/2010CN1927202B Vitamin E nicotinate microcapsule and its preparing process
10/13/2010CN1919207B Gariic and medlar capsule
10/13/2010CN1875979B Soft capsule of hippophae rhamnoides and preparation process thereof
10/13/2010CN1823890B Formula of oral Chinese medicine used for treating virus myocarditis
10/13/2010CN1628829B Chinese medicine for treating hypertension, high blood fat and high blood sugar
10/13/2010CN1433326B Method for determining viability of myocardial segment
10/13/2010CN101861328A Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders
10/13/2010CN101861319A Benzazepinone compound
10/13/2010CN101861156A Adherent cells from adipose or placenta tissues and use thereof in therapy
10/13/2010CN101861149A N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases
10/13/2010CN101857854A Mesenchymal stem cell for expressing related gene of neurotrophin family and application thereof
10/13/2010CN101857598A Furocoumarin compound with hypertension activity reducing function and preparation method thereof
10/13/2010CN101857594A Tetrahydropyridoindole compounds, and preparation method and application thereof
10/13/2010CN101856498A Anti-septic shock medicine compound and application thereof
10/13/2010CN101856493A Compound piracetam brain protein hydrolysate tablet and preparation method thereof
10/13/2010CN101856490A Method for preparing Sini decoction granules from unprocessed radix aconiti lateralis
10/13/2010CN101856485A Chinese medicament for treating hypertension
10/13/2010CN101856480A Chinese medicament for treating myocardial infarction
10/13/2010CN101856471A Chinese medicinal composition for tonifying kidney and strengthening body
10/13/2010CN101856466A Medicine preventing and treating hypertension and stroke and being prepared by dendrobium officinale flower and method
10/13/2010CN101856460A Chinese medicament for treating hypotension
10/13/2010CN101856454A Chinese medicament for treating haemorrhoid
10/13/2010CN101856443A Method for preparing Chinese patent medicament arisaema cum bile
10/13/2010CN101856439A Chestnutsdispe capsule and preparation method thereof
10/13/2010CN101856433A Application of Puer tea in preparing dugs for preventing oxidative stress caused by immunosenescence or other relevant disease thereof
10/13/2010CN101856428A Chinese medicament for treating hypertension and preparation method thereof
10/13/2010CN101856421A Medicament for treating herpes zoster and preparation method thereof
10/13/2010CN101856403A Medicinal composition, preparation method thereof and pharmaceutical application
10/13/2010CN101856398A Chinese medicinal composition for clearing heat and cooling blood, promoting blood circulation and stopping pain and preparation and detection method
10/13/2010CN101856392A Chinese medicament for treating heart disease
10/13/2010CN101856389A Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases and application thereof
10/13/2010CN101856357A Application of rotundic acid in preparing medicines for preventing and treating cardiovascular and cerebrovascular diseases
10/13/2010CN101856353A Medicinal composition using tolperisone optical isomer as active ingredient
10/13/2010CN101856351A Composition and use thereof in preparation of RXR receptor transcription inhibitor
10/13/2010CN101856326A Method for preparing medical lycorine emulsion
10/13/2010CN101502635B Medicament composition containing Reserpine
10/13/2010CN101468993B Isoquinolinium compound or its salts, pharmaceutical composition containing the same, preparation and use thereof
10/13/2010CN101396366B Solid oral preparation containing valsartan and preparation method thereof
10/13/2010CN101362729B Valsartan postprocessing method
10/13/2010CN101327213B 厄贝沙坦氢氯噻嗪药用组合物及其制备方法 Irbesartan Hydrochlorothiazide pharmaceutical composition and its preparation method
10/13/2010CN101322712B Alprostadil nano granule formulation and preparation thereof
10/13/2010CN101258875B Yoghourt useful for lowering blood fat and preparation
10/13/2010CN101152233B Pharmaceutical composition of snakegourd fruit and folium ginkgo
10/13/2010CN101138555B Application of octacosanol in the preparation of medicament for treating and preventing hypoxic pulmonary hypertension
10/13/2010CN101129828B Traditional Chinese medicine for treating cataptosis
10/13/2010CN101121696B Metal salt of pyritinol and hydrate of the same
10/13/2010CN101103030B Medicaments with HM74A receptor activity
10/13/2010CN101088507B Application of ophiopogoni D in preparing gene medicine for regulating vasular endothelial cell period
10/13/2010CN101041629B New process for the synthesis and new crystalline form of agomelatine and pharmaceutical compositions containing it
10/13/2010CN101007014B A compound puerarin preparation
10/12/2010US7812178 such as (R)-3-(3-hydroxypyrrolidin-1-yl)-N-methyl-N-methoxypropanamide; poly(ADP-ribose)polymerase inhibitors
10/12/2010US7812169 Angiogenesis inhibitors; vision defects; anticancer agents; retinopathy; skin disorders; antiarthritic agents; antitumor agents; aids
10/12/2010US7812146 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7811997 From bamboo using carbon dioxide Supercritical Fluid Extraction; a mixture comprising friedelin,lupenone and homologues; hypotensive agents; anticarcinogenic agents; antitumor agents; free radical scavengers; oxidation resistance; cardiovascular disorders; sin, hair cosmetics; oral administration
10/12/2010US7811992 Measuring binding of Bradykinin and angiogensin receptor; calibration; animal hibernation
10/12/2010US7811991 Polypeptide therapeutic for treating ischemia associated with perioperative surgical procedure
10/12/2010US7811985 Treatment and prophylaxis of reperfusion injuries, particularly after cardiac necrosis; administering an N-terminus modified polypeptide derived from the A alpha chain of fibrinand the B beta chain of fibrin; antiinflammatory agents
10/12/2010US7811590 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010US7811549 Concurrently administering a synergistic mixture of adenosine and dipyridamole by parenteral injection, or intraveinous or intra-arterial bolus to cause coronary vasodilation for cardiac diagnosis
10/12/2010US7811314 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation
10/12/2010CA2480038C Substituted 4-aminocyclohexanols
10/12/2010CA2457050C Prophylactic and therapeutic use of hydroxysteroids
10/12/2010CA2455863C Tetrahydroquinoline derivatives as gamma secretase inhibitors
10/12/2010CA2455526C Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof
10/12/2010CA2445512C A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
10/12/2010CA2441110C Pharmaceutical compositions for treating arteriosclerosis
10/12/2010CA2427352C Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase
10/12/2010CA2413699C Topical pharmaceutical formulations and methods of treatment
10/12/2010CA2410556C Konjac mannan and polysaccharide compositions and uses thereof
10/12/2010CA2397964C Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
10/12/2010CA2382317C Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
10/12/2010CA2339761C Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
10/07/2010WO2010114801A1 Oral formulations of diphenylsulfonamide endothelin and angiotensin ii receptor agonists to treat elevated blood pressure and diabetic nephropathy
10/07/2010WO2010114181A1 Acrylamide compounds and the use thereof
10/07/2010WO2010113958A1 Pharmaceutical composition for treatment or prevention of ophthalmic diseases
10/07/2010WO2010113900A1 Production method for ubiquinone powder for use in preparations and product thereof
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113631A1 Agent for amelioration or prevention of metabolic syndrome
10/07/2010WO2010113022A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010WO2010112865A1 5-ht receptor modulating compounds
1 ... 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 ... 1595